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The membrane bound melanocortin 1 receptor (MC1R), and the endothelin B receptor
(ENDBR) are two G-protein coupled receptors that play important roles in constitutive
regulation of melanocytes and their response to ultraviolet radiation (UVR), the main
etiological factor for melanoma. The human MC1R is a Gs protein-coupled receptor,
which is activated by its agonists α-melanocyte stimulating hormone (α-melanocortin;
α-MSH) and adrenocorticotropic hormone (ACTH). The ENDBR is a Gq coupled-
receptor, which is activated by Endothelin (ET)-3 during embryonic development, and
ET-1 postnatally. Pigmentation and the DNA repair capacity are two major factors that
determine the risk for melanoma. Activation of the MC1R by its agonists stimulates
the synthesis of eumelanin, the dark brown photoprotective pigment. In vitro studies
showed that α-MSH and ET-1 interact synergistically in the presence of basic fibroblast
growth factor to stimulate human melanocyte proliferation and melanogenesis, and
to inhibit UVR-induced apoptosis. An important function of the MC1R is reduction of
oxidative stress and activation of DNA repair pathways. The human MC1R is highly
polymorphic, and MC1R variants, particularly those that cause loss of function of the
expressed receptor, are associated with increased melanoma risk independently of
pigmentation. These variants compromise the DNA repair and antioxidant capacities of
human melanocytes. Recently, activation of ENDBR by ET-1 was reported to reduce the
induction and enhance the repair of UVR-induced DNA photoproducts. We conclude
that α-MSH and ET-1 and their cognate receptors MC1R and ENDBR reduce the risk
for melanoma by maintaining genomic stability of melanocytes via modulating the DNA
damage response to solar UVR. Elucidating the response of melanocytes to UVR should
improve our understanding of the process of melanomagenesis, and lead to effective
melanoma chemoprevention, as well as therapeutic strategies.
Keywords: melanocortin 1 receptor, endothelin B receptor, melanocytes, melanoma, ultraviolet radiation,
photoprotection, DNA repair
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INTRODUCTION
Epidermal melanocytes are pigment producing cells that are
derived from the neural crest during embryonic development
and are responsible for the distinctive skin coloration (Adams
and Bronner-Fraser, 2009). Once they populate the epidermis,
the majority of melanocytes are fully differentiated, and similar
to neurons, have a long life span and a low proliferative
capacity. Disruption of the homeostasis of melanocytes results in
pigmentary disorders, the most extreme of which are vitiligo, an
acquired depigmentary disorder caused by loss of melanocytes,
and melanoma, the deadliest form of skin cancer caused by
uncontrolled proliferation due to mutations in genes such as
CDKN2A, and/or by reduced DNA repair capacity due to
mutations in genes such as the melanocortin 1 receptor gene
(MC1R; Alikhan et al., 2011; Abbas et al., 2014). The significance
of melanocytes lies in their photoprotective role against the
genotoxic effects of solar ultraviolet radiation (UVR; Kadekaro
et al., 2003). The pigment melanin, which is deposited in
specialized organelles, melanosomes, that are transferred from
melanocytes to keratinocytes, shields the nuclei of these cells
from impinging UV rays, and also acts as a scavenger of reactive
oxygen species that can damage DNA, proteins and lipids (Pathak
et al., 1980; Bustamante et al., 1993). Genetic and in vitro
studies showed that melanocyte homeostasis is regulated by many
genes, including those that code for growth factor receptors,
transcription factors, and their targets (Kondo and Hearing,
2011). In vitro studies showed that mammalian, including
human, melanocytes are regulated by signaling pathways that
are activated by G-protein coupled receptors and tyrosine kinase
receptors (Halaban et al., 1988a; Abdel-Malek et al., 1995a,b;
Swope et al., 1995; Imokawa et al., 1997; Kunisada et al., 1998;
Tada et al., 1998; Figure 1). These pathways and their crosstalk
regulate the melanocytes constitutively, as well as their response
to their micro- and macro-environment, mainly solar UVR, the
major etiological factor for melanoma.
Role of Melanins in Photoprotection
Melanin produced by melanocytes, is the main photoprotective
mechanism against UVR-induced photodamage, the underlying
cause of skin cancers, including melanoma (Pathak et al., 1971;
Pathak, 1995; Gilchrest et al., 1999). It is common knowledge
that individuals with fair skin who have a poor tanning ability
are at a higher risk for skin cancers, including melanoma,
than individuals with dark skin (Dubin et al., 1989; Halder
and Bridgeman-Shah, 1995). Human melanocytes synthesize
both eumelanin, the dark brown pigment, and pheomelanin,
the red–yellow pigment (Hunt et al., 1995a; Wakamatsu et al.,
2006). The ratio of eumelanin to pheomelanin is an important
determinant of skin color, and correlates directly with total
melanin content. In human melanocytes, it is eumelanin, rather
than pheomelanin content, that determines the extent of skin
pigmentation (Hennessy et al., 2005; Wakamatsu et al., 2006).
It is known that eumelanin is more photoprotective than
FIGURE 1 | Paracrine regulation of human melanocytes by the keratinocyte-derived melanocortins, ET-1 and basic fibroblast growth factor (bFGF).
Keratinocytes synthesize α-MSH and adrenocorticotropic hormone (ACTH), the agonists of MC1R, ET-1, the agonist of the endothelin B receptor (ENDBR), and
bFGF, the ligand for bFGF receptor tyrosine kinase (RTK). When these receptors are activated, the crosstalk of their signaling pathways stimulates human
melanocyte proliferation, melanogenesis and survival. Melanocytes transfer melanin-containing melanosomes to keratinocytes, a photoprotective mechanism that
reduces the genotoxic effects of solar UVR.
Frontiers in Genetics | www.frontiersin.org 2 August 2016 | Volume 7 | Article 146
fgene-07-00146 August 12, 2016 Time: 16:51 # 3
Swope and Abdel-Malek MC1R and ENDBR Regulation of Melanocytes
pheomelanin due to its resistance to photodegradation, its ability
to shield the skin from UVR and to scavenge reactive oxygen
radicals (Menon et al., 1983; Nofsinger et al., 2002; Meredith and
Sarna, 2006). Eumelanin content has been shown to correlate
inversely with the induction of DNA photoproducts in the skin
in situ, as well as in human melanocytes in vitro (Tadokoro et al.,
2003; Hauser et al., 2006). Pheomelanin, on their other hand,
is photolabile and can be a pro-oxidant (Panzella et al., 2014).
It was reported that pheomelanin promotes melanomagenesis
via induction of oxidative DNA damage in mice harboring
the activating Brafv600E mutation, without exposure to any
carcinogen, such as UVR (Mitra et al., 2012). This suggests
that pheomelanin can be oncogenic. Recently, the induction
of UVR-induced DNA photoproducts in melanin-containing
melanocytes and keratinocytes was found to increase even after
cessation of UVR exposure, and this increase was greater in
the skin of K14-Kitl / mc1re/e (recessive yellow) mice than
in the skin of black K14-Kitl mice expressing wild type mc1r
(Premi et al., 2015). This difference in DNA photoproducts
was attributed to pheomelanin in the skin of transgenic
recessive yellow mice. The elevated DNA photoproducts in
these mice can possibly overwhelm the DNA repair capacity,
thus increasing the chance for mutations, the underlying cause
of skin cancer, including melanoma. These findings clearly
indicate that the photoprotective effects of eumelanin vs.
pheomelanin are not merely due to their differential ability to
act as a physical barrier that reduces the penetration of UVR
through the epidermal layers, and emphasize the significance of
elucidating the role of these melanins in determining the risk for
melanoma.
THE MC1R, A Gs PROTEIN-COUPLED
RECEPTOR EXPRESSED ON
MELANOCYTES
The main regulator of eumelanin synthesis in mammalian
melanocytes is the melanocortin 1 receptor (MC1R), a Gs
protein-coupled receptor that is activated upon binding of
α-melanocyte stimulating hormone (α-melanocortin; α-MSH;
Silvers, 1961; Mountjoy et al., 1992). Genetic studies on
mouse coat color identified the mc1r as the major regulator
of pheomelanin/eumelanin switch in follicular melanocytes
(Geschwind et al., 1972; Tamate and Takeuchi, 1984). The
recessive yellow mutation in mouse mc1r results in loss of
function (LOF) of the receptor and in yellow coat color,
due to the exclusive production of pheomelanin (Tamate and
Takeuchi, 1984; Robbins et al., 1993). In vivo studies showed
that injection of human subjects with purified melanocortins
induced an increase in pigmentation (Lerner and McGuire,
1961). This effect was corroborated by the finding that injection
of human subjects with the potent α-MSH analog NDP-MSH
increased skin pigmentation in the absence of any sun exposure
(Levine et al., 1991). However, from these studies, it could
not be determined whether or not melanocortins had a direct
effect on melanocytes. In the early 1990’s, the cloning of
the MC1R from human melanocytes and the demonstration
that the expressed receptor is functional provided strong
evidence in support of the significance of MC1R in regulating
human pigmentation by directly affecting melanin synthesis in
melanocytes (Mountjoy et al., 1992; Abdel-Malek et al., 1995b).
As its mouse ortholog, activation of the human MC1R by
the potent α-MSH analog NDP-MSH increased the synthesis
of eumelanin by human melanocytes (Hunt et al., 1995b).
It was established that α-MSH and ACTH bind the human
MC1R with the same affinity, thus both are considered to
be physiological agonists of the receptor (Suzuki et al., 1996).
As has been shown for the mouse mc1r, agouti signaling
protein functions as an inverse agonist of the human MC1R,
competitively inhibiting the binding of α-MSH and reducing
the basal levels of tyrosinase, the rate-limiting enzyme in the
melanin synthetic pathway (Suzuki et al., 1997). More recently,
it was demonstrated that human β-defensin 3 also functions as
an antagonist of the human MC1R (Candille et al., 2007; Swope
et al., 2012).
The cAMP Pathway, the Main Signaling
Pathway Activated by MC1R
The MC1R is a Gs protein-coupled receptor with seven
transmembrane domains that is expressed on the cell surface
of melanocytes and signals mainly through activation of the
cAMP pathway (Suzuki et al., 1996; Garcia-Borron et al.,
2014). It belongs to the family of melanocortin receptors
(MC1-5R), and is the only MCR expressed on melanocytes
(Suzuki et al., 1996). Since the 1970’s, it has been known
that α-MSH activates the synthesis of cAMP, as demonstrated
in vitro using mouse melanoma cells, and that the rise in
cAMP levels stimulates the activity of tyrosinase, thus increasing
melanin synthesis (Kreider et al., 1973; Pawelek et al., 1973;
Wade and Burkart, 1978; Legros et al., 1981). The effect of
α-MSH on pigmentation was mimicked by dibutyryl cAMP
(db cAMP), and by phosphodiesterase inhibitors, such as
theophylline and isobutyl methylxanthine (IBMX), that prevent
cAMP degradation. Injection of newborn mice with either
α-MSH or db cAMP resulted in increased number of dopa-
positive melanocytes, suggesting stimulation of melanoblast
differentiation (Hirobe and Takeuchi, 1977). These early studies
established that α-MSH activates the cAMP pathway, which
mediates its pigmentary effect.
Later, the cAMP pathway was reported to enhance the
proliferation and stimulate pigmentation of primary mouse
and human melanocytes (Eisinger and Marko, 1982; Tamura
et al., 1987; Abdel-Malek et al., 1992). Treatment of human
melanocytes with α-MSH increases the activity of tyrosinase,
and this effect is mimicked by forskolin, a direct activator of
adenylate cyclase (Abdel-Malek et al., 1995b; Scott et al., 2002;
Kadekaro et al., 2010). The proliferation of human melanocytes
in culture is stimulated by the crosstalk of the cAMP-, protein
kinase C (PKC)- and/or tyrosine kinase receptors-dependent
pathways. The first culture medium for primary human
melanocytes contained 12-o- tetradecanoylphorbol ester (TPA),
which activates PKC, and cholera toxin and IBMX, which
increase intracellular cAMP levels by activating adenylate
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cyclase and inhibiting phosphodiesterase, respectively (Eisinger
and Marko, 1982). By binding and activating their cognate
receptor tyrosine kinases, basic fibroblast growth factor (bFGF),
hepatocyte growth factor (HGF) and stem cell factor (SCF)
stimulate melanocyte proliferation in the presence of a cAMP
stimulator (Halaban et al., 1988b; Matsumoto et al., 1991;
Grichnik et al., 1998). Human melanocyte cultures can be
established and maintained in growth medium containing
bFGF, endothelin-1 (ET-1), which increases intracellular calcium
concentration and activates PKC, and α-MSH (Swope et al.,
1995). These three factors interact synergistically to stimulate
melanocyte proliferation and melanogenesis (Figure 1).
The crosstalk of the signaling pathways of these growth
factors activates the MAP kinases ERK1/2, known to regulate
melanocyte proliferation (Bohm et al., 1995; Tada et al.,
1998). Interestingly, bFGF, SCF, HGF, ET-1, α-MSH, and
ACTH are all synthesized in the epidermis, thus function
as paracrine factors that maintain melanocyte homeostasis
(Halaban et al., 1988a; Imokawa et al., 1992; Schauer et al., 1994;
Wakamatsu et al., 1997; Kakurai et al., 2002; Mildner et al.,
2007).
MC1R Variants and Their Impact on
Receptor Function
The MC1R is a major contributor to the diversity of human
pigmentation. Epidemiological studies identified many
polymorphisms of the MC1R (close to 200 allelic variants)
that are expressed in different human populations (Garcia-
Borron et al., 2014). The wild type MC1R is predominantly
expressed in Africa, where dark skin with high eumelanin
content is needed for adaption to the equatorial sun (Harding
et al., 2000). Certain variants associated with fair skin and
red hair phenotype, mainly R151C, R160W, and D294H, are
highly expressed in Northern European populations, and in
the Celtic population of Australia (Box et al., 1997; Smith
et al., 1998). The association of this pigmentary phenotype with
increased melanoma risk implicated the MC1R in melanoma
predisposition (Palmer et al., 2000; Box et al., 2001; Kennedy
et al., 2001; van der Velden et al., 2001; Landi et al., 2005;
Kanetsky et al., 2006). However, expression of the above three
allelic variants is necessary but not sufficient for red hair
phenotype, as they are also expressed in individuals with dark
skin and hair color (Palmer et al., 2000; Kennedy et al., 2001;
Landi et al., 2005; Han et al., 2006; Stratigos et al., 2006; Pasquali
et al., 2015). Expression of these variants increased melanoma
risk independently of skin or hair color, as confirmed by studies
conducted on Southern Italian and Greek populations. Analysis
of large data that included 5160 melanoma cases and 12,119
controls revealed that expression of the nine most common
MC1R variants, R151C, R160W, D294H, V60L, R142H, D84E,
I155T, R163Q, and V92M, increased melanoma risk, and this
was observed in darkly pigmented Caucasians (Pasquali et al.,
2015). These findings confirm previous results showing that
carriage of two low risk MC1R variants (V92M or R163Q), or
any high risk variant (R151C, R160W, or D294H) is associated
with increased melanoma risk, mostly in individuals with
dark skin, limited sun exposure, and good tanning response
(Kanetsky et al., 2010). These epidemiological results concluded
that melanoma risk cannot be accurately ascertained based
only on pigmentary phenotype, and suggested that MC1R
regulates other functions in melanocytes, independently of
pigmentation.
Using primary cultures of human melanocytes expressing
different MC1R genotypes, or heterologous cells transfected
with wild type or a MC1R variant, revealed that the red
hair allelic variants, R151C, R160W, and D294H, result in
LOF of the MC1R by impairing its functional coupling to
Gs protein, thus inhibiting its signaling via increasing cAMP
synthesis (Scott et al., 2002; Ringholm et al., 2004; Kadekaro
et al., 2010). Others reported that melanocytes homozygous
for R151C or R160W have impaired binding of α-MSH to
the MC1R (Beaumont et al., 2005). However, this was not the
case for D294H variant. Expression of any two of these three
variants as homozygous or compound heterozygous causes loss
of MC1R function in human melanocytes, as determined by
lack of response to α-MSH by increasing intracellular cAMP
levels and tyrosinase activity (Scott et al., 2002; Kadekaro et al.,
2010). Melanocytes expressing LOF MC1R responded normally
to forskolin, confirming that the inability to respond to α-MSH
is due to a defect at the level of the receptor, and not its
downstream signaling pathway. The variant V60L, which is
associated with blond hair, results in reduction, not total loss, of
MC1R activity (Kadekaro et al., 2010). The very common alleles
V92M, and R163Q that is mainly expressed in Southeast Asia,
did not alter the activity of the MC1R, and are considered as
pseudoalleles. Despite the findings that the activity of the MC1R
encoded for by R163Q variant is comparable to that encoded
by the wild type allele, the resulting pigmentary phenotypes
are not identical, suggesting that allelic variants of the MC1R
alter the interaction of MC1R with other genes that regulate
pigmentation.
The MC1R has seven transmembrane domains. Site-
directed mutagenesis of the MC1R revealed that the second
transmembrane domain is critical for agonist binding, and the
second intracellular loop is essential for coupling to Gs and
stimulating cAMP synthesis (Sanchez Mas et al., 2002). The
R151C and R142H substitutions, which are associated with red
hair and result in impaired MC1R signaling, are both located
in the second intracellular loop of the receptor. Some MC1R
variants impair the trafficking of the receptor and hence reduce
its cell surface expression. This has been reported for the red
hair allelic variants R151C and R160W, as well as for D84E
and I155T, but not for the red hair variant D294H (Beaumont
et al., 2005). Expression of MC1R variants had no impact
on MC1R protein levels, suggesting that reduced number of
membrane bound receptors is not due to decreased stability of
the protein. It was reported that R151C impairs MC1R trafficking
by retaining it in the endoplasmic reticulum, and that R160W
results in MC1R retention in the cis-Golgi (Sanchez-Laorden
et al., 2009). Phosphorylation of T157 and the 160RARR163 motif
were shown to be critical for normal receptor trafficking and
are conserved in all five members of the melanocortin receptors
family.
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Effect of MC1R on UVR-Induced DNA
Damage in Melanocytes
Given the significance of pigmentation in photoprotection and
that tanning is a hallmark of exposure to UVR, the role
of melanocortins and the MC1R in the response of human
melanocytes to UVR has been the subject of investigation in
a number of laboratories. It was reported that activation of
the cAMP pathway is critical for stimulating melanogenesis in
cultured human melanocytes exposed to UVR (Im et al., 1998).
Later, it was reported that melanocytes expressing two red hair
allelic variants, hence LOF MC1R, have increased sensitivity to
UVR, as determined by increased melanocyte death by apoptosis
following UVR exposure (Scott et al., 2002). During the past
decade, a novel and paradigm shifting role for MC1R signaling
was described, namely enhancement of repair of UVR-induced
DNA damage in human melanocytes. The ability of α-MSH
to enhance repair of UVR-induced DNA photoproducts was
first reported independently by us and by Bohm et al. (2005;
Kadekaro et al., 2005). It is known that DNA photoproducts
are formed by the direct absorption of UVR by pyrimidine
bases in DNA, predominantly at sites containing a thymine (TC,
TT; Budden and Bowden, 2013). These photoproducts create
bulky lesions that distort the DNA helix, forming adducts that
can halt transcription and DNA replication. If not repaired
efficiently, the sustained DNA damage due to presence of
photoproducts can result in mutations, the underlying cause
of skin cancers, including melanoma. The significance of the
activated MC1R and the cAMP pathway on DNA repair was
further confirmed by other investigators (Smith et al., 2008;
Jarrett et al., 2014). These reports established the role of the
MC1R in regulating DNA repair in melanocytes, in addition to
its well- known function as the main regulator of eumelanin
synthesis.
Irradiation of melanocytes with UVR also results in the
generation of oxidative DNA damage, in addition to DNA
photoproducts (Denat et al., 2014). We showed that treatment of
melanocytes with α-MSH reduced the UVR-induced generation
of reactive oxygen species, increased the activity and levels of
catalase, a first-line-of-defense antioxidant enzyme, as well as
the levels of ferritin, another anti-oxidant protein (Song et al.,
2009). As expected, these effects resulted in reduced generation
of 8-oxodeoxyguanosine (8-oxodG), the major form of oxidative
DNA damage. Others reported the effects of α-MSH on activation
of Nrf2, a transcription factor that regulates the expression
of genes that code for phase II detoxifying enzymes, such as
heme oxygenase-1 and glutathione s-transferase Pi, by binding
to the antioxidant response elements in their promoters (Kokot
et al., 2009). Another transcription factor that was found to be
pivotal for reducing oxidative DNA damage in melanocytes is
p53 (Kadekaro et al., 2012). Treatment with α-MSH contributed
to the UVR-induced accumulation of p53 in melanocytes, and
silencing of p53 abolished the inhibitory effect of α-MSH on
hydrogen peroxide-induced oxidative DNA damage. Activation
of transcription factors, such as Nrf2 and p53, by α-MSH strongly
suggested its transcriptional regulation of antioxidant genes
involved in the response of melanocytes to UVR.
Microarray experiments provided compelling evidence for
the transcriptional effects of MC1R, particularly on genes that
are involved in the regulation of the cell cycle, DNA repair,
antioxidant defenses, apoptosis, and pigmentation (Kadekaro
et al., 2010). Treatment with α-MSH reversed the effects of
UVR on the expression of many genes involved in these
functional categories, which is consistent with the results of
functional assays demonstrating reduced oxidative DNA damage
and enhanced repair of DNA photoproducts and survival.
Importantly, we reported that these effects of α-MSH require
expression of functional MC1R, and are absent in melanocytes
expressing LOF MC1R, due to expression of two red hair color
allelic variants. The findings that melanocytes with LOF MC1R
have reduced DNA repair and antioxidant capacities provide
an explanation for the vulnerability of these melanocytes to
malignant transformation to melanoma.
MC1R and the DNA Damage Response of
Melanocytes to UVR
Exposure to UVR triggers a DNA damage response (DDR), a
signal transduction pathway that coordinates cell cycle transition,
DNA repair, and apoptosis, in order to prevent genomic
instability (Cimprich and Cortez, 2008). Efficient DNA repair, an
integral component of the DDR to UVR, is critical for evasion
of photocarcinogenesis (Kraemer et al., 1994; DiGiovanna and
Kraemer, 2012). The role of MC1R in the DDR of human
melanocytes to UVR is illustrated in Figure 2. Our investigation
of the role of the MC1R in the DDR of melanocytes to UVR
revealed that activation of the MC1R by α-MSH binding resulted
in the phosphorylation, hence activation of the DNA damage
sensors ataxia telangiectasia mutated (ATM) and Rad3 related
(ATR), ATM, and DNA-PK (Kadekaro et al., 2012; Swope et al.,
2014). Treatment with α-MSH increased the levels of Chk1
and Chk2, the immediate downstream targets of ATR and
ATM, as well as the transcription factor p53, and γ-H2AX,
the phosphorylated form of histone 2AX (Swope et al., 2014).
Accumulation of p53 and its transactivation are important for
cell cycle arrest, DNA repair, and apoptosis of cells with damaged
DNA (Gomez-Lazaro et al., 2004). Formation of γ-H2AX is
critical for recruitment of DNA repair proteins to DNA damage
sites (Celeste et al., 2002). As expected, these effects of α-MSH
were absent in melanocytes expressing LOF MC1R. Treatment
with α-MSH also increased the levels of XPC, the enzyme
involved in recognition of DNA damage, the first step in
nucleotide excision repair, the main repair pathway for DNA
photoproducts (Hanawalt, 2002). The significance of activation
of DNA damage sensors by α-MSH was further demonstrated
by the findings that activation of the MC1R, which results in
increased cAMP levels and activation of the cAMP-dependent
PKA, induces the phosphorylation of ATR on Ser 435, and
that phosphorylation of this site is required for association
of ATR with the DNA repair protein XPA (Jarrett et al.,
2014). Collectively these results provide compelling evidence
for the significance of the MC1R and its signaling pathway
in modulating the response of melanocytes to UVR, which is
expected to maintain genomic stability and prevent melanoma
formation.
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FIGURE 2 | The signaling pathways of MC1R and ENDBR modulate the
DNA damage response (DDR) of human melanocytes to UVR. Irradiation
with UVR increases the synthesis and release of α-MSH and ET-1 by
keratinocytes. Binding of α-MSH to MC1R stimulates the synthesis of cAMP
that activates PKA, which in turn activates DNA damage sensors, increases
DNA repair proteins, and activates the transcription factor Nrf-2, which
increases the expression of phase II antioxidant genes. Endothelin-1 binds
ENDBR and activates intracellular Ca2+ mobilization and PKC, leading to
phosphorylation of ERK1/2, and enhances the UVR-induced phosphorylation
of JNK and p38. The signaling pathways of MC1R and ENDBR converge on
activation of the transcription factors MITF and p53, resulting in increased
melanocyte survival, repair of UVR-induced DNA damage, antioxidant
defenses and pigmentation.
THE ENDOTHELIN-B RECEPTOR, A Gq
PROTEIN-COUPLED RECEPTOR
EXPRESSED ON THE CELL SURFACE OF
MELANOCYTES
Another important G-protein coupled receptor with critical role
in the maintenance of melanocyte survival and homeostasis is the
Endothelin-B receptor (ENDBR), a Gq-coupled receptor that is
expressed on the cell surface of melanocytes (Tada et al., 1998;
Mizuno et al., 2005). The ENDBR is the receptor for Endothelin
(ET)-3 that is expressed during prenatal life on melanoblasts,
the precursors of melanocytes (Lee et al., 2003). Activation of
ENDBR by ET-3 binding is critical for the survival and migration
of neural crest-derived cells, including melanoblasts. Mutations
that disrupt the expression of either ENDBR or ET-3 gene result
in Hirschsprung’s disease, characterized by unpigmented skin
lesions due to loss of melanoblasts, and a megacolon due to
absence of enteric ganglia that have the same embryonic origin
as melanocytes (Baynash et al., 1994). The ENDBR is also the
receptor of ET-1 that is expressed postnatally, and has the
same binding affinity and effects as ET-3 (Tada et al., 1998).
There are two ET receptors, ENDAR and ENDBR (Rubanyi
and Polokoff, 1994). The latter is the predominant receptor
expressed by human melanocytes (Tada et al., 1998). Activation
of ENDBR by ET-1 increases intracellular Ca2+ mobilization
and PKC activity. Endothelin-1 is a 21-amino acid peptide
that is derived from a larger inactive pro-peptide (Rubanyi
and Polokoff, 1994). It is synthesized by keratinocytes, and its
expression is increased upon UVR exposure (Imokawa et al.,
1992, 1995).
Role of ET-1/ENDBR Axis in the
Regulation of Melanocytes and the
Crosstalk of ENDBR and MC1R Signaling
Pathways
Endothelin-1 was first described as a potent mitogen for human
melanocytes (Yada et al., 1991; Imokawa et al., 1992). We reported
that ET-1 interacts synergistically with α-MSH and bFGF to
stimulate human melanocyte proliferation and melanogenesis,
and to reduce UVR-induced apoptosis (Swope et al., 1995; Tada
et al., 1998; Kadekaro et al., 2005). The synergistic effects of
ET-1, α-MSH and bFGF led us to utilize them in a growth
medium for maintenance of human melanocytes in culture, in
place of non-physiological mitogens, such as TPA or cholera
toxin (Swope et al., 1995). Activation of ENDBR also reduces
the generation of reactive oxygen species, which should decrease
oxidative DNA damage (Kadekaro et al., 2005). The signaling
pathways and the effects of ET-1 are summarized in Figure 2.
Activation of ENDBR results in increased phosphorylation of
the mitogen activated MAP kinase ERK1/2, the transcription
factor CREB, and the downstream transcription factor Mitf (Tada
et al., 2002; Kadekaro et al., 2005). The synergistic interaction
of ENDBR with MC1R involves enhanced activation of Mitf,
increased expression of its target the anti-apoptotic Bcl2, and
increased phosphorylation of Akt, which increases survival by
inhibiting the pro-apoptotic Bad (Kadekaro et al., 2005). We
also reported that treatment of human melanocytes with ET-1
increases their migration, while treatment with α-MSH promotes
adhesion (Scott et al., 1997). Another important effect of ET-1
is up regulation of expression of MC1R, which is expected to
increase MC1R expression on the cell surface of melanocytes,
and sustain their response to α-MSH (Tada et al., 1998; Swope
et al., 2012). These results demonstrate the significance of
ENDBR and MC1R, two distinct G protein-coupled receptors,
and the various means of interaction of their signaling pathways
in regulating melanocyte survival and function. Additionally,
these results underscore the significance of the paracrine factors
α-MSH and ACTH, and ET-1, in maintenance of melanocyte
homeostasis.
Effect of ENDBR/ET-1 Axis in Repair of
UV-Induced DNA Photoproducts
Recently, we found that treatment with ET-1 reduces the
induction and enhances the repair of cyclobutane pyrimidine
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dimers (CPDs), the major form of DNA photoproducts, in
UVR-irradiated human melanocytes (von Koschembahr et al.,
2015). The effects of ENDBR/ET-1 axis on the DDR response
of human melanocytes to UVR are summarized in Figure 2.
Endothelin-1 was more effective than α-MSH in enhancing CPD
repair, since this effect was evident at concentrations ≤ 1 nM,
compared to 10 nM α-MSH. The effects of ET-1 on CPD
repair and survival were mediated by increased intracellular
Ca2+ mobilization, and the downstream activation of the stress-
induced MAP kinases JNK and p38. Others have reported that
increased expression of ET-1 reduced UVR-induced CPDs in
mouse skin (Hyter et al., 2013). An important finding is that
treatment with ET-1 enhanced repair of CPDs in melanocytes
expressing LOF MC1R, suggesting that activation of ENDBR
and its signaling pathways can compensate for loss of MC1R
signaling in melanocytes (von Koschembahr et al., 2015).
Therefore activation of ENDBR is a mechanism to counteract
the genotoxic effects of UVR in melanocytes, regardless of
their MC1R genotype. We are further investigating the effects
of ENDBR and MC1R signaling on the DDR of melanocytes
to UVR to identify common, as well as distinct downstream
effectors that are involved in reducing the genotoxic effects of
UVR.
MELANOCORTIN ANALOGS FOR
PREVENTION OF SKIN CANCERS,
INCLUDING MELANOMA
For decades, there has been interest in developing melanocortin
analogs that can stimulate pigmentation without sun exposure
(sunless tanning). There were also many attempts to tag
melanocortin analogs to chemotherapeutic agents to selectively
eradicate melanoma tumor cells (Abdel-Malek, 2010). The
best known and most studied melanocortin analog is NDP-
MSH (Ac-[Nle4, D-Phe7]-α-MSH), which proved to be at
least 100-fold more potent, and markedly most stable and
with more prolonged effects than the native α-MSH in
amphibians, reptiles and mammals (Sawyer et al., 1980,
1982; Marwan et al., 1985). NDP-MSH was also more
potent and had a more prolonged effect than α-MSH on
tyrosinase activity of cultured human melanocytes (Abdel-Malek
et al., 2006). Systemic administration of NDP-MSH to human
volunteers demonstrated its efficacy in inducing pigmentation
in the absence of any sun exposure (Levine et al., 1991).
More recently, the photoprotective effect of NDP-MSH was
demonstrated by the reduction of sun-induced DNA damage
in subjects treated with this analog (Barnetson et al., 2006).
However, the administration of NDP-MSH resulted in side
effects, including nausea and loss of appetite (Levine et al.,
1991), which can be attributed to binding and activating
other melanocortin receptors expressed on cells other than
melanocytes.
With the discovery that α-MSH enhances DNA repair
and activates antioxidant defenses, in addition to stimulating
eumelanin synthesis, we became interested in developing small
analogs of α-MSH with high selectivity and specificity for the
MC1R. This is important in drug development in order to avoid
any off-target effects. It has been shown that the core 6–9 amino
acid residues of α-MSH, His-Phe-Arg-Trp, are required for its
melanogenic activity (Hruby et al., 1987; Castrucci et al., 1989).
Based on this, we developed n-capped tetrapeptide analogs,
containing this core sequence, or tripeptides, consisting of His-
Phe-Arg sequence, in which L-Phe was replaced by D-Phe,
which is known to confer stability to the peptide (Abdel-Malek
et al., 2006; Abdel-Malek et al., 2009). These n-capped analogs
were tested for their potency on human melanocytes, using
stimulation of cAMP synthesis and tyrosinase activity as two
endpoints. Based on these assays, we selected the most potent
tetra- and tripeptide analogs, some of which proved to be
highly selective for MC1R, with very low, or no affinity for the
remaining melanocortin receptors. These analogs, like α-MSH,
enhanced repair of CPDs and reduced the generation of reactive
oxygen species in UVR-irradiated human melanocytes, and are
being further tested in preclinical assays to insure their efficacy
and safety. The lipophilic property of these analogs, together
with their small size and low molecular weight, is expected to
enhance their skin permeation when applied topically. Similar
to α-MSH, these analogs require the expression of functional
MC1R, and will have no effect on individuals expressing LOF
MC1R. Despite this limitation, developing these analogs as
a skin cancer, including melanoma, prevention strategy will
benefit millions who are heterozygous for MC1R variants,
and have a high risk for melanoma due to reduced MC1R
activity. Carriers of one MC1R variant represent about 50%
of all White Caucasians (Schaffer and Bolognia, 2001). Our
analogs should also benefit individuals who are carriers of
mutations in other melanoma predisposition genes, such as
CDKN2A.
Our finding that activation of ENDBR enhances repair
of DNA photoproducts in melanocytes makes it attractive
to harness the ENDBR signaling pathway for a melanoma
prevention strategy that can globally benefit high risk individuals,
regardless of MC1R genotype (von Koschembahr et al.,
2015). The ENDBR is ubiquitously expressed, thus it cannot
be targeted directly for melanoma prevention. However,
downstream effectors of ENDBR that impact the DDR of
melanocytes can potentially be targeted for this purpose.
Studies are underway to identify such downstream effectors
that can also be activated by MC1R, or are specific to ENDBR
signaling.
CONCLUSION
The MC1R and ENDBR are two important G protein-coupled
receptors that have multiple effects on melanocytes, ensuring
their homeostasis, and modulating their DDR to UVR by
reducing DNA damage, enhancing survival, and stimulating
melanin synthesis. The human MC1R agonists, α-MSH and
ACTH, and ENDBR ligand, ET-1, are paracrine factors,
whose synthesis by epidermal keratinocytes is increased
upon UVR exposure. These ligands, in turn, up regulate
the expression of the MC1R. Additionally, α-MSH and
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by analogy ACTH, interact synergistically with ET-1 to stimulate
melanocyte proliferation and survival. The vast interest in MC1R
stems from its high polymorphism and its role as a melanoma
susceptibility gene. The novel finding that ET-1, similar to
α-MSH and ACTH, enhances DNA repair in melanocytes,
identifies a novel mechanism by which melanocytes evade
UVR-induced photocarcinogenesis. That activation of ENDBR
signaling can compensate for LOF of MC1R opens the door for
designing novel prevention strategies for high risk individuals,
irrespective of their MC1R genotype.
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